SAN DIEGO--(BUSINESS WIRE)--Aug. 9, 2006--AVANIR Pharmaceuticals (NASDAQ: AVNR) today reported unaudited financial results for the Company’s fiscal third quarter ended June 30, 2006.
SAN DIEGO--(BUSINESS WIRE)--Aug. 9, 2006--AVANIR Pharmaceuticals (NASDAQ: AVNR) today reported unaudited financial results for the Company’s fiscal third quarter ended June 30, 2006.